U. Muscha Steckelings

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Activation of AT2 receptors prevents diabetic complications in female db/db mice by NO‐mediated mechanisms”.

Activation of AT2 receptors prevents diabetic complications in female db/db mice by NO‐mediated mechanisms

British Journal of Pharmacology(2020)10.1111/bph.15241

N/A

0.638DataRank · unranked

14 citations

Luciana C. Veiras, Justin Z. Y. Shen, Ellen A. Bernstein, D. Quiroga, U. Muscha Steckelings +3 more

Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists

Clinical Science(2020)10.1042/cs20200922

N/A

0DataRank · unranked

40 citations

Colin Sumners, U. Muscha Steckelings

Targeting angiotensin type-2 receptors located on pressor neurons in the nucleus of the solitary tract to relieve hypertension in mice

Cardiovascular Research(2021)10.1093/cvr/cvab085

N/A

0DataRank · unranked

27 citations

Dominique N. Johnson, Lei Wang, Scott W. Harden, Wanhui Sheng, Eliot Spector +9 more

Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension

Cardiovascular Research(2022)10.1093/cvr/cvac130

N/A

0DataRank · unranked

140 citations

Tazeen H. Jafar, Neil R. Poulter, Albertino Damasceno, Nadia Khan, Peter M. Nilsson +34 more

The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target

Pharmacological Reviews(2022)10.1124/pharmrev.120.000281

N/A

0DataRank · unranked

86 citations

Robert E. Widdop, Edward D. Sturrock, Lizelle Lubbe, Tahir Hussain, Elena Kaschina +5 more